We compared the changes in heart rate (HR), pulmonary dynamic compliance (Cdy.), and pulmonary conductance (GL) associated with three different models of anaphylaxis in genetically mast cell-deficient WBB6Fj-W/W' and congenic normal (+/+) mice. Intravenous infusion of a monoclonal rat antimouse IgE produced a marked tachycardia, diminutions in Cda. and GL, and death in +/+ but not W/W' mice, and +/+ mice sensitized to develop high circulating levels of IgE exhibited HR, Cd,,, and GL responses to rat anti-IgE challenge which were significantly less intense than those in nonimmunized +/+ mice. By contrast, virtually identical cardiopulmonary responses were observed in either +/+ or W/W' mice challenged to elicit pure active anaphylactic responses or simultaneous active and anti-IgE-dependent anaphylaxis. These findings show that anaphylactic responses associated with significant tachycardia, reductions in Cdy. and GL, and death can occur in the virtual absence of tissue mast cells. This is true even though, in normal mice, such responses are associated with extensive degranulation of tissue mast cells. By contrast, certain models of anaphylaxis, such as that induced in nonsensitized mice by anti-mouse IgE, can not be elicited in the absence of mast cells. (J. Clin. Invest. 1991. 88:598-608.)
Introduction
Several lines of evidence indicate that mast cells represent a potentially critical source of the mediators responsible for the cardiopulmonary alterations associated with IgE-dependent anaphylactic responses (1) (2) (3) (4) . IgE has been strongly implicated in the pathogenesis of anaphylactic bronchoconstriction (5); mast cells express large numbers of surface receptors (FcqRI)I that bind IgE with high affinity (6) (7) (8) ; mast cells can be triggered via FcRI to release potent bronchoactive mediators (1-4, 6-1 1); and agents that interfere either with mast cell degranulation or the effects of mast cell-associated mediators can diminish the expression of anaphylactic responses (12) (13) (14) (15) (16) . Finally, we reported that genetically mast cell-deficient mice challenged intravenously (i.v.) with goat anti-mouse IgE (goat anti-IgE) antibodies survived and failed to develop abnormalities ofcardiopulmonary function (17) . By contrast, identically treated congenic normal mice rapidly developed peribronchial mast cell degranulation, tachycardia, diminished pulmonary dynamic compliance (Cdyn) and conductance (GL), and, in 8 of 13 cases, death within 60 min of injection of anti-IgE (17) .
However, it has been suggested that mast cells may not importantly contribute to certain types of anaphylactic responses. Morphological studies showed that sensitized mice expressing fatal active anaphylaxis upon antigen challenge exhibited no detectable activation of mast cell populations in the skin or mesentery (18, 19) . More recently, Jacoby et al. (20) and Ha et al. (21, 22) found that antigen challenge ofsensitized genetically mast cell-deficient mice was as likely to result in their death as was identical challenge of sensitized congenic normal mice. Ha et al. (22) also reported that when serum from actively sensitized mast cell-deficient mice was heated to destroy the ability ofIgE to bind to Fc receptors, the serum lost its ability to transfer anaphylactic responsiveness to nonsensitized mice. This suggested that IgE antibodies had an essential role in this model of anaphylaxis, whereas mast cells did not. The expression of fatal, IgE-dependent anaphylaxis by mice virtually devoid ofmast cells is in accord with evidence that many cell types in addition to the mast cell can release potent biologically active mediators by IgE-dependent mechanisms. Such cells include basophils stimulated via their FcfRI ( 1-5, 7, 8) , as well as macrophages, platelets, lymphocytes, and perhaps eosinophils activated via receptors (FcRII/CD23) that can bind IgE with low affinity (23-25).
1. Abbreviations used in thispaper: ANOVA, analysis ofvariance; Cdy, pulmonary dynamic compliance; Fc.RI, surface receptors that bind IgE antibodies with high affinity; FcRII/CD23, surface receptors that bind IgE antibodies with low affinity; goat anti-IgE, affinity-purified goat anti-mouse IgE; goat anti-Mb, affinity-purified goat anti-mouse IgD; GL, pulmonary conductance; HR, heart rate; PEEP, positive end expiratory pressure; rat anti-DNP, affinity-purified rat monoclonal anti-DNP; rat anti-IgE, affinity-purified rat monoclonal anti-mouse
Even though previous work clearly demonstrated that fatal active anaphylaxis can occur in the virtual absence of mast cells, these studies relied on observations of prostration or death as the indicators of a clinical response (20) (21) (22) . As a result, it was not possible to compare specific cardiopulmonary responses associated with active anaphylaxis in mast cell-deficient mice to those in normal mice. Moreover, the previous studies did not include histological analysis to determine whether the anaphylactic responses were associated with mast cell activation. In fact, Jacoby et al. (20) reported that normal mice expressing active anaphylaxis did not exhibit detectable changes in lung histamine content, suggesting that the model of anaphylaxis studied was not associated with significant activation ofmast cell populations. In the present study, we analyzed the changes in heart rate (HR), CdY., and GL, as well as the occurrence of death, in genetically mast cell-deficient WBB6F,-W/W' and congenic normal (WBB6F1-+/+) mice expressing active anaphylaxis to i.v. goat IgG, anaphylaxis induced by i.v. injection ofa rat monoclonal anti-mouse IgE (rat anti-IgE), or a combination of active and anti-IgE-dependent anaphylaxis induced by i.v. injection ofa goat anti-mouse IgE. We also examined the tissues of these mice to quantify the extent of mast cell activation associated with the various models of anaphylaxis.
Methods
Animals. We studied male genetically mast cell-deficient WBB6F,-W/ WY (W/lY') mice and the congenic normal (WBB6F,-+/+) mice ([WB/ReJ-W/+ X C57BL/6J-W/+]F,-[ W/lY', +/+] mice; Jackson Biological Laboratory, Bar Harbor, ME), which were 12-16 wk old (25-35 g of body wt) at the beginning of the experiment. The W/W' mice have mutations at the W locus on chromosome 5, which encodes the c-kit tyrosine kinase growth factor receptor (26) . W/W' mice are anemic, lack melanocytes in the skin, are sterile, and virtually lack tissue mast cells (27, 28) . The skin of adult W/W' mice contains < 0.5% the number ofmast cells present in the skin ofthe congenic +/+ mice, and no mast cells whatsoever are identifiable in the trachea, lungs, or multiple other organs or anatomical sites (17, 27, 28) . However, apart from defects in responses significantly influenced by mast cells, the expression of immunological and inflammatory reactions in W/W' mice is similar or identical to that in the congenic normal animals (21, (28) (29) (30) Materials. Pentobarbital sodium was obtained from Anthony Products Co., Arcadia, CA. Affinity purified goat anti-mouse IgE (goat anti-IgE) was prepared as described for rabbit anti-mouse IgE (31) . In brief, goats were immunized with monoclonal mouse IgE, their immune serum was absorbed with mouse serum-Sepharose, IgD,-Sepharose, and IgM,-Sepharose, then mixed with normal mouse serum overnight and centrifuged to remove soluble complexes. The supernatant was bound to and then eluted from IgE-Sepharose, and then dialyzed against 0.85 M NaCl. The generation and affinity purification of a rat monoclonal (mc) anti-mouse IgE antibody has been described in detail (32) . As a control reagent, we used affinity-purified rat mc anti-DNP (a gift from Dr. Herve Bazin, Brussels, Belgium) of the same isotype (IgG2a) as the rat mc anti-mouse serum IgE. Affinity-purified goat anti-mouse IgD antibodies (goat anti-Mb) were prepared as previously described in detail (33 Fig. 1 .
A dose-response effect for the cardiopulmonary changes induced by rat anti-IgE was observed both in nonsensitized and sensitized mice. However, cardiopulmonary responses in sensitized mice were generally less marked than those in nonsensitized mice, especially for GL and HR at a dose of 100 ,g of rat anti-IgE and for Cd,,, and GL at 30 ,g of rat anti-IgE. By ANOVA, responses of sensitized and nonsensitized mice were different at the P < 0.001 level for Cdyn, GL, and HR at 100 Ag of rat anti-IgE. None of the maximal changes in GL in sensitized mice were significant by the two-tailed Mann-Whitney U test, but the GL responses to 30 or 100 Mug of rat anti-IgE were significant when compared to those to rat anti-DNP by the one-tailed test (P < 0.05 for either comparison). Even though sensitization rendered +/+ mice somewhat less responsive to the cardiopulmonary effects associated with i.v. administration of rat anti-IgE, deaths occurred at lower doses of rat anti-IgE challenge in sensitized than in nonsensitized mice. Thus, the numbers of sensitized mice that died within 60 min of challenge with 15, 30, or 100 Mg of rat anti-IgE were two of five, three of five, and two of five, respectively, whereas the corresponding values for the nonsensitized mice were zero of five, zero of five, and three of five. There were no deaths among mice treated with the control reagent, rat anti-DNP.
Cardiopulmonary responses to challenge with rat anti-DNP (control antibody) or during variousforms ofanaphylactic challenge in mast cell-deficient W/W'1 and congenic +/+ mice.
Groups of nonsensitized and goat anti-Mb-sensitized mast cell-deficient W/Wv and congenic normal (+/+) mice were challenged i.v. with 100 ,ug ofrat anti-DNP (as a control, Fig. 2 A), rat anti-mouse IgE (Fig. 2 B) , goat IgG (Fig. 2 C) , or goat anti-mouse IgE (Fig. 2 D) , and the Cdy,,,, GL, and HR responses were recorded until death or 60 min after challenge, which ever occurred first. Note that the groups of +/+ mice challenged with 100Mg ofrat anti-IgE or rat anti-DNP presented in Fig. 2 , A and B, are the same as those shown in Fig. 1 . Table III reports for each of the four treatment groups the mean ± SEM of the lowest recordings of Cd,,Y, or GL, and the highest recording of HR, for each mouse during the first 20 min after challenge. Table IV summarizes the statistical significance of comparisons within the four treatment groups, determined by using ANOVA to compare responses recorded over the first 20 min after challenge. Table V summarizes the statistical significance of comparisons between values recorded in the first 20 min after challenge in the negative control (anti-DNP treated) as opposed to each of the three experimental groups. Table VI reports the death rates and times until death in the four treatment groups. Fig. 3 shows the numbers of dermal and peribronchial mast cells, and the extent of dermal and peribronchial mast cell activation, in sensitized and nonsensitized +/+ mice in the four treatment groups.
Mice challenged with rat anti-DNP. Neither the genotype of the mice nor their sensitization status significantly influenced responses to rat anti-DNP (Table IV) . Mice injected with rat anti-DNP (Fig. 2 A) exhibited a slight gradual diminution of Cdy,,, with mean maximal decreases to 94-96% ofbaseline by 20 min after injection (Table III) , and also exhibited a gradual diminution in HR, to mean levels 60 min after injection which ranged from 65±1% to 70±4% of baseline values (Fig. 2 A) . The values of Cd,,,, or HR recorded in the four groups ofmice tested were quite consistent, with most SEM at individual time points . 10% or 15% of the mean, respectively. As in our previous study (17) , values for GL exhibited more variability than those for Cd,,, or HR, with SEM of < 20% ofthe mean at all time points. Sensitization status had no effect on either numbers of dermal or peribronchial mast cells or on morphological evidence of mast cell activation in +/+ mice (Fig. 3) . Thus > 90% of dermal or peribronchial mast cell populations in either the sensitized or nonsensitized group appeared normal. None of the mice challenged with rat anti-DNP died within 60 min of injection (Table VI) .
Mice challenged with rat anti-IgE. Injection ofrat anti-IgE produced a dramatic anaphylactic response in both sensitized and nonsensitized +/+ mice but not in either group of W/WI mice (Fig. 2 B) (Fig. 3) . Three of five nonsensitized mice and two of five sensitized mice died within 60 min of challenge with rat anti-IgE (Table VI) In contrast to our findings in +1+ mice, administration of rat anti-IgE to W/W' mice was virtually without effect (Fig. 2  B) . Sensitized W/WV mice exhibited a slight tachycardia (Table  III) , which was significant when compared to the responses in either nonsensitized W/W1 mice challenged with rat anti-IgE (Table IV) or the responses in sensitized W/WV mice challenged with rat anti-DNP (Table V) . However, neither sensitized nor nonsensitized W/W' mice exhibited significant changes in Cdyl, or GL (Tables III, IV , and V). None of the W/W9' mice challenged with rat anti-IgE died within 60 min of injection (Table VI) .
Mice challenged with goat IgG. As would be expected for active anaphylaxis responses, sensitized +/+ mice challenged with goat IgG exhibited dramatic responses, whereas nonsensitized control +/+ mice were unresponsive (Fig. 2 C) . However, sensitized mast cell-deficient W/W' mice also exhibited striking, and in some cases fatal, active anaphylactic responses (Fig.  2 C) . Death occurred within 60 min of goat IgG challenge in three of five sensitized +/+ mice and in two of five sensitized W/WV mice, but in none ofthe nonsensitized mice (Table VI) .
In sensitized +/+ or W/WV mice, goat IgG challenge produced diminutions in Cdy. and GL that were similar to those observed in sensitized +/+ mice challenged with rat anti-IgE (Table III) . These responses were significant (P < 0.001) when compared either to the corresponding values in mice challenged with rat anti-DNP (Table V) or to the values obtained in nonsensitized mice challenged with goat IgG (Table IV) .
However, the CdYn and GL responses in sensitized +/+ mice challenged with goat IgG were statistically indistinguishable from those obtained in identically challenged sensitized W/W' mice (Table IV ).
An unexpected finding was that the HR responses differed dramatically in mice expressing rat anti-IgE-induced anaphylaxis as opposed to active anaphylaxis (compare Fig. 2 , B and C). Sensitized WBB6F,-+/+ mice developed a striking tachycardia upon challenge with rat anti-IgE (Fig. 2 B) , whereas the HR response in sensitized +/+ mice challenged with goat IgG (i.e., a -gradual diminution in HR, Fig. 2 C) was not significantly different from that observed in mice challenged with the control reagent, rat anti-DNP (Fig. 2 A and Tables III and V) . The HR in nonsensitized mice challenged with goat IgG actually was slightly less than that in nonsensitized +/+ mice challenged with rat anti-DNP (Table III) . This small difference was significant (P < 0.01) over the first 20 min (Table V) but not over the full 60 min after injection. The HR in nonsensitized +/+ mice challenged with goat IgG was also slightly less than that in identically challenged nonsensitized W/W' mice ( Fig. 2  C and Table IV ). The small differences in the HR responses of various groups ofnonsensitized mice challenged with goat IgG, and the slightly higher value for GL in goat IgG as opposed to rat anti-DNP challenged nonsensitized +/+ mice (Tables III  and V) , are of uncertain biological significance.
Histological analysis showed that challenge of sensitized +/+ mice with goat IgG resulted in activation of dermal mast cells which was significant when compared to findings in either nonsensitized goat IgG challenged or nonsensitized rat anti-DNP challenged groups (P < 0.001 for either comparison, Fig.   3 ). However, dermal mast cell degranulation was not as marked as in sensitized or nonsensitized +/+ mice challenged with rat anti-IgE (Fig. 3) . When peribronchial mast cells of goat IgG challenged +/+ mice were examined, small numbers of mast cells exhibiting changes consistent with slight activation were observed in both sensitized and nonsensitized groups (Fig. 3) . Again, these changes were much less striking than those observed in +/+ mice challenged with rat anti-IgE. Ex (Fig. 2, B vs. D, Tables III through VI). CdY., GL, and HR responses, as well as death rates and extent of mast cell degranulation (Fig. 3) , were very similar in nonsensitized +/+ mice challenged with rat or goat anti-IgE, whereas nonsensitized Wit-P mice were essentially unresponsive to either rat or goat anti-IgE.
Mice sensitized to goat anti-Mb would be expected to exhibit an active anaphylaxis response to i.v. injection of goat anti-IgE. However, in +/+ mice, such active anaphylaxis would occur simultaneously with responses induced by antiIgE-dependent activation of mast cell populations. Sensitized +/+ mice challenged with goat anti-IgE exhibited significant diminutions in Cdyn or GL, which were very similar to those observed in sensitized +/+ mice challenged with either rat anti-IgE or goat IgG (Table III) . However, these mice also developed a significant tachycardia which was virtually identical in magnitude to that seen in sensitized mice challenged with rat anti-IgE. By contrast, +/+ mice experiencing active anaphylaxis to goat IgG did not develop tachycardia (Table III) .
Even though death rates were identical in sensitized or nonsensitized +/+ mice challenged with goat anti-IgE (Table VI) , the nonsensitized mice developed a diminution in GL and an elevation of HR which were significantly greater (P < 0.001) than those observed in identically challenged sensitized mice (Fig. 2 D and Tables III and IV) . Nonsensitized +/+ mice also developed significantly more intense degranulation of dermal or peribronchial mast cells upon goat anti-IgE challenge than did the sensitized +/+ animals (Fig. 3) .
Sensitized WIW' mice challenged with goat anti-IgE developed changes in Cdy,, and GL that were similar to those observed in sensitized W/W' mice challenged with goat IgG (Tables III, IV, and V). However, unlike the W/WV mice expressing active anaphylaxis to goat IgG, sensitized W/WV mice challenged with goat anti-IgE developed a significant tachycardia (Fig. 2 D with rat anti-IgE. However, some WBB6F1-+/+ mice sensitized with goat anti-Mb died when challenged with 15 or 30 jg of rat anti-IgE, whereas no fatalities occurred in similarly challenged control mice. Thus, sensitization resulted in a change in WBB6F1-+/+ mice which rendered them more susceptible than control mice to anti-IgE-induced fatal anaphylactic responses, even though they were less susceptible than controls to the effects ofanti-IgE on mast cell activation and cardiopulmonary responses. We recently found that sensitization of mice with goat anti-Mb strikingly increases basophil levels (45), suggesting that anti-IgE-induced basophil activation may contribute to fatal anaphylactic responses in sensitized mice.
In contrast to responses induced by rat anti-IgE, active anaphylaxis to goat IgG challenge was not associated with tachycardia. In fact, HR responses in +/+ mice exhibiting active anaphylaxis were statistically indistinguishable from those in +/+ mice challenged with rat anti-DNP. In either instance, HR gradually and progressively declined throughout the period of observation. By contrast, +/+ mice expressing active anaphylaxis did develop a significant reduction in CdY., which was similar in magnitude to that observed in nonsensitized +/+ mice challenged with rat anti-IgE (to 79±2% vs. 80±2% of baseline in the first 20 min after challenge, respectively). They also developed a significant drop in GL, although not as marked as that in nonsensitized +/+ mice challenged with rat anti-IgE (75±5% vs. 48±5% of baseline in the first 20 min after challenge, respectively, P <0.008). Active anaphylaxis was also associated with significantly less mast cell degranulation than was observed in either sensitized or nonsensitized +/+ mice challenged with rat anti-IgE. Thus, in mice expressing active anaphylaxis to IgG, 59±12% of dermal mast cells and 80±3% of peribronchial mast cells exhibited no morphological evidence of degranulation, whereas these values were . 211±1% in +/+ mice challenged with rat anti-IgE (Fig. 3) .
Even though active anaphylaxis to goat IgG was associated with less dramatic mast cell degranulation and less impressive cardiopulmonary changes than occurred in mice challenged with rat anti-IgE, the death rates in these two models of anaphylaxis were identical (three of five) and the times until death in mice which succumbed before the end ofthe 60-min period of observation were very similar (Table VI) . We do not know why rat anti-IgE-induced anaphylaxis was associated with a striking tachycardia whereas active anaphylaxis to goat IgG was not. However, we already have reported that in a different model of active anaphylaxis +/+ mice develop tachycardia whereas WIW" mice do not (46) . Taken together, our previous study (46) and the present one indicate that distinct models of active anaphylaxis may be associated with strikingly different cardiopulmonary responses. WBB6F1-+/+ mice sensitized to goat anti-Mb and challenged with goat anti-mouse IgE expressed simultaneously an active anaphylactic response to the goat antibodies and an anti-IgE-dependent response. The changes in HR, Cdyn, and GL in these mice were very similar to those recorded in sensitized +/+ mice challenged with rat anti-IgE (Table III) whereas the extent of mast cell degranulation was somewhat less (Fig.  3) Careful histological analysis confirmed that the tissues of the WI/W mice remained virtually devoid of mast cells at the end of the experiment, ruling out the possibility that the sensitization protocol somehow resulted in the development of mast cell populations in these animals (42) . This experiment thus confirmed, using the goat anti-Mb model of active anaphylaxis, results obtained by Jacoby et al. (20) and Ha et al. (21, 22) , indicating that fatal active anaphylaxis responses can be expressed in the virtual absence of tissue mast cells. However, our findings extend the previous work by demonstrating that the mast cell-deficient mice exhibit pulmonary function changes associated with active anaphylaxis which are not distinguishable from those in normal mice containing mast cells. Thus, mast cells are not required for the development of the changes in pulmonary mechanics associated with at least some models of active anaphylaxis.
One explanation for the expression of active anaphylaxis in mast cell-deficient mice would be that the model of anaphylaxis tested occurred by mechanisms which failed to activate tissue mast cells in normal mice. However, this explanation was ruled out by our histological analysis, which indicated that +/+ mice expressing active anaphylaxis exhibited significant activation of dermal mast cell populations (Fig. 3) . On the other hand, these +/+ mice exhibited only modest activation of peribronchial mast cell populations, a response which was significant when compared to that in sensitized +/+ mice challenged with the control reagent, rat anti-DNP, but which was not significant when compared to the findings in nonsensitized +/+ mice challenged with goat IgG (Fig. 3) . Ifthese results were to be considered in the absence of studies in mast cell-deficient mice, one might be tempted to attribute the pulmonary changes associated with active anaphylaxis in +/+ mice to the effects of mediators released into the circulation by dermal and perhaps other nonbronchial mast cell populations. However, the findings in W/lY" mice clearly show that diminished pulmonary compliance and conductance can occur during active anaphylaxis by mechanisms completely independent ofcontributions by mature mast cells.
Infusion of rat anti-mouse IgE into nonsensitized W/W" mice had no discernable effect on HR, Cdy.,, or GL, findings consistent with those of our previous study (17) . However, in W/W" mice with high levels of IgE as a result ofimmunization with goat anti-Mb, injection ofrat anti-mouse IgE produced a modest but highly significant tachycardia (P < 0.001 vs. values in sensitized W/W' mice challenge with rat anti-DNP). The tachycardia response in sensitized W/JV mice challenged with goat anti-mouse IgE was even more striking. Indeed, it was statistically indistinguishable from the response in the corresponding group of +/+ mice (Table III) anti-IgE, goat IgG, or goat anti-IgE. 1-,Mm-thick, Epon-embedded, Giemsa-stained sections of the ear pinnae or major bronchi were examined as described in the text to quantify the numbers of mast cells per square millimeter of dermis or peribronchial tissues, and to assess the extent of mast cell activation in the tissues. Data, which are expressed as mean±SEM, are from the same mice shown in Fig. 2 
